Company Filing History:
Years Active: 2025
Title: Jung-Ae Kim: Innovator in Autoimmune Disease Treatment
Introduction
Jung-Ae Kim is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autoimmune diseases. Her innovative work has led to the development of a unique compound that shows promise in addressing serious health conditions.
Latest Patents
Jung-Ae Kim holds a patent for a "Heteroarylamidopyridinol derivative and pharmaceutical composition comprising same as active ingredient for prevention or treatment of autoimmune disease." This invention specifically targets inflammatory bowel disease and rheumatoid arthritis. The heteroarylamidopyridinol derivative has demonstrated an excellent effect in inhibiting TNF-α- or IL-6-induced monocyte adhesion to gut epithelial cells. It has also been proven to have a therapeutic effect on these autoimmune diseases in vivo. This innovative compound can be advantageously used for the treatment of autoimmune diseases, particularly inflammatory bowel disease and rheumatoid arthritis.
Career Highlights
Jung-Ae Kim is currently associated with Innovo Therapeutics Inc., where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Jung-Ae Kim collaborates with notable colleagues, including Byeong-Seon Jeong and Tae-gyu Nam. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Jung-Ae Kim is a trailblazer in the field of pharmaceutical innovation, particularly in the treatment of autoimmune diseases. Her patented work represents a significant advancement in medical science, offering hope for effective treatments for conditions like inflammatory bowel disease and rheumatoid arthritis.